Information on the clinical utility of neuropsychological tests in non-Nort
h-American samples is limited. We examined the diagnostic efficacy of the C
onsortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsyc
hological battery in Jamaican men and women age 65 and older. A total of 72
elders were diagnosed as normal and 12 were demented based on history, phy
sical, and neurological examination. Independent of this medical examinatio
n, participants were tested with the CERAD battery. Normal controls scored
significantly better than dementia patients on all tests in the CERAD batte
ry. A discriminant function found that a combination of Word List Learning
Sum Recall and Boston Naming Test correctly classified a total of 81% of th
e cases (83% of the dements and 81% of the normal controls). This study is
the first to demonstrate the clinical utility of the CERAD neuropsychologic
al battery in the differential diagnosis of memory disorders of the aged in
a non-North-American sample.